崔映宇 副教授
硕士招生类型：学术型
硕士招生专业：基础医学
博士招生类型：学术型
博士招生专业：基础医学
所在院系：医学院
联系方式：yycui@tongji.edu.cn,
课题组链接：
研究方向
主要任职
科研业绩

天然活性物质的生物学效应及细胞分子机制 Cellular and molecular mechanism of the bioactive natural products’ effects
《当代癌症报道》杂志主编 Editor-in-Chief of Current Cancer Reports (ISSN:2661-3166)
Seminars in Cancer Biology, British Journal of Pharmacology, Journal of Pharmacology and Experimental Therapeutics等国际学术期刊审稿人
科研课题：
1. New targets for atrial fibrillation therapy. (National Key R&D Program of China, No.2018YFC**)；
2.Regulation of mitochondrial homeostasis by protein machinery and its role in heart diseases. (Fundamental Research Funds for the Central Universities, No. )；
3.Practice and Exploration of Research-based Leaching in Basic Course of Life Medicine (Shanghai Educational Research Project 2019-2021. No.C19154)
科研论文：
1. Zeng YX, Wang S, Wei L, Cui YY*, Chen YH. Proanthocyanidins: Components, Pharmacokinetics and Biomedical Properties. American Journal of Chinese Medicine. 2020; 48(4):813-869；
2.Zeng YX, Wang S, Wei L, Cui YY*. Primary investigation on effects of Pinus massoniana bark extract inducing senescence of hepatoma HepG2 cells. Current Cancer Reports 2020; 2(1):34-40；
3. Geng L, Wang S, Zhang F, Xiong K, Huang J, Zhao T, Shi D, Lv F, Li L, Liang D, Cui Y, Liu Y, Xie D, Chen YH. SNX17 (Sorting Nexin 17) Mediates Atrial Fibrillation Onset Through Endocytic Trafficking of the Kv1.5 (Potassium Voltage-Gated Channel Subfamily A Member 5) Channel. Circulation: Arrhythmia and Electrophysiology.2019; 12(4):e007097.doi: 10.1161/CIRCEP.118.007097；
4. Ying-Yu Cui. Cancer, mankind’s challenge. Current Cancer Reports 2019; 1(1):1-5；
5. Ying-Yu Cui. Establishment and Validation of Human Colon Cancer HCT116 wip1 FLAG Knock-in Cell Line.Annals of Mutagenesis, 2017, 1(1): 3-6；
6. Lin, Bo-Wen; Gong, Cheng-Chen; Song, Hai-Fei; Cui, Ying-Yu*. Effects of anthocyanins on the prevention and treatment of cancer. British Journal of Pharmacology, 2017, 174(11):1226-1243；
7.Feng Jiao, Zhang Xiao-Lu, Li Ying-Ya, Cui Ying-Yu★, Chen YH. Pinus massoniana Bark Extract: Structure-Activity Relationship and Biomedical Potentials. American Journal of Chinese Medicine. 2016; 44(8):1559-1577；
8. Ying-Ya Li; Jiao Feng; Xiao-Lu Zhang; Meng-Qi Li; Ying-Yu Cui★. Effects of Pinus massoniana bark extract on the invasion capability of HeLa cells. Journal of Functional Foods 2016; 24(5): 520-526；
9.Ying-Ya Li, Jiao Feng, Xiao-Lu Zhang, Ying-Yu Cui★.Pine bark extracts: Nutraceutical, Pharmacological, and Toxicological Evaluation. Journal of Pharmacology and Experimental Therapeutics 2015, 353(1):9-16；
10. Dan-Chen Wu, Shuai Li, Da-Qing Yang, Ying-Yu Cui★. Effects of Pinus massoniana bark extract on the adhension and migration capabilities of HeLa cells. Fitoterapia 2011, 82(8):1202-1205；
11. Cui YY, Xie H, Qi KB, He YM, Wang JF. Effects of Pinus massoniana bark extract on cell proliferation and apoptosis in human hepatoma BEL-7402 cells. World J Gastroenterol 2005, 11 (34): 5277-5282；
12. Cui YY，Xie H, Wang JF. Potential biomedical properties of Pinus massoniana bark extract (PMBE), Phytother Res 2005, 19 (1): 34-38
授权专利：崔映宇, 李梦琪, 李响, 李俊, 陈义汉. 马尾松树皮提取物在制备移植器官保存液中的应用. 2020-04-14, 中国ZL 2017 1 **. X.